z-logo
open-access-imgOpen Access
Toolbox: Psychotropic medications approved in children and adolescents
Author(s) -
Robin Hieber
Publication year - 2013
Publication title -
mental health clinician
Language(s) - English
Resource type - Journals
ISSN - 2168-9709
DOI - 10.9740/mhc.n145473
Subject(s) - toolbox , psychology , medicine , psychiatry , computer science , programming language
Medication Brand Name(s) Daily Dosage Range Notes Methylphenidate Immediate Release (IR) Methylin® Ritalin® 10-60 mg Give in divided doses, second dose typically noon or early afternoon For children ≥6 years Methylphenidate Sustained (SR)/Extended Release (ER) Ritalin SR® Metadate SR® Methylin ER® Quillivant XR® (extended release oral suspension) Concerta® Metadate CD® Ritalin LA® 20-60 mg Concerta: 18-72 mg Oral suspension needs to be shaken vigorously for 10 seconds Concerta®: 22% IR, 78% ER Metadate CD®: 30% IR, 70% ER Ritalin LA®: 50% IR, 50% ER For children ≥6 years

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom